Novo Integrated Sciences(NVOS) - 2024 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___, 20, to __, 20. Commission File Number: 001-40089 Novo Integrated Sciences, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 59-3691650 (Stat ...